Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00350883 · ClinicalTrials.gov registry record · Phase 2
Cognitive Therapy for Negative Symptoms and Functioning
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 61
- Enrollment target
NCT00350883: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT00350883 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00350883, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 61 participants
- Enrollment target
Study Summary
This clinical trial tests the effectiveness of cognitive therapy (CT) to improve outcomes in outpatients diagnosed with schizophrenia or schizoaffective disorder who manifest prominent negative symptoms. It is hypothesized that patients receiving cognitive therapy will manifest lower negative symptom levels and improved engagement in constructive activity relative to patients who receive treatment-as-usual. Further, it is predicted that these differences between CT and TAU will be larger when patients are assessed 6 and 12 months after the end of treatment (18 and 24 months after study entry).
Interventions
- OTHER Treatment as Usual
- BEHAVIORAL Cognitive Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2006-07 |
| Est. Completion | 2011-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00350883
The ClinicalTrials.gov registry entry for NCT00350883 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT00350883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00350883 about?
NCT00350883 is a clinical study titled "Cognitive Therapy for Negative Symptoms and Functioning". This clinical trial tests the effectiveness of cognitive therapy (CT) to improve outcomes in outpatients diagnosed with schizophrenia or schizoaffective disorder who manifest prominent negative symptoms. It is hypothesized that patients receiving cognitive therapy will manifest lower negative sympto...
What is the current status of trial NCT00350883?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 61 participants. The study started on 2006-07. Estimated completion is 2011-11.
What interventions are being tested in trial NCT00350883?
The interventions under investigation include: Treatment as Usual (OTHER), Cognitive Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00350883?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.